Glory Health Industry Limited (HKG:2329)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0950
+0.0070 (7.95%)
Jul 31, 2026, 4:08 PM HKT

Glory Health Industry Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1,822-1,240-563.97-912.78228.33
Depreciation & Amortization
51.1280.8783.4996.2792.67
Other Amortization
0.848.7811.7926.76132.57
Loss (Gain) From Sale of Assets
799.7117.72-146.12-2.45-332.01
Asset Writedown & Restructuring Costs
-47.88498.94-263.5-20.06-115.7
Loss (Gain) on Equity Investments
-69.9372.56-42.03-166.39
Provision & Write-off of Bad Debts
219.1359.6459.2688.08112.23
Other Operating Activities
1,3031,129418.7942.62682.24
Change in Accounts Receivable
-374.44-1,369-488.38512.95142.79
Change in Inventory
154.151,7652,6222,8606,410
Change in Accounts Payable
-793.86159.99729.34-177.131,431
Change in Unearned Revenue
599.89-499.52-2,018-2,771-4,418
Change in Other Net Operating Assets
-14.03-1.61-3.75.51145.45
Operating Cash Flow
75.05679.53512.92606.314,345
Operating Cash Flow Growth
-88.96%32.48%-15.40%-86.05%-12.01%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-21.61-1.28-60.81-192.85-279.54
Sale of Property, Plant & Equipment
-0.33-11.861.04
Divestitures
-0.01-195.88-36.78307.1
Sale (Purchase) of Real Estate
----70.9468.65
Other Investing Activities
-837.57147.67-76.12-16.786.9
Investing Cash Flow
-859.19146.7258.96-305.41184.15

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
862.85133.7826.98188.6-
Long-Term Debt Issued
3126.635280.592,252
Total Debt Issued
865.85260.3861.98469.192,252
Short-Term Debt Repaid
-----2,410
Long-Term Debt Repaid
-67.18-163.47-213.94-691.52-4,273
Total Debt Repaid
-67.18-163.47-213.94-691.52-6,683
Net Debt Issued (Repaid)
798.6796.91-151.96-222.33-4,432
Other Financing Activities
-37.84-927.41-475.44-408.58-1,223
Financing Cash Flow
760.82-830.5-627.4-630.91-5,654

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-23.32-4.25-55.52-330.01-1,125

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
53.44678.26452.11413.474,066
Free Cash Flow Growth
-92.12%50.02%9.35%-89.83%-12.86%
Free Cash Flow Margin
5.16%25.07%18.04%10.59%41.08%
Free Cash Flow Per Share
0.010.150.100.090.92
Levered Free Cash Flow
389.68-1,327-213.9391.711,318
Unlevered Free Cash Flow
919.27-700.17100.23373.951,784

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
37.84927.41475.44408.581,223
Cash Income Tax Paid
0.15-305.16-29.37-143.61304.31
Change in Working Capital
-428.2855840.71429.913,711